Cefradroxil en es it fr

Cefradroxil Brand names, Cefradroxil Analogs

Cefradroxil Brand Names Mixture

  • None

Cefradroxil Chemical_Formula


Cefradroxil RX_link


Cefradroxil fda sheet

Cefradroxil msds (material safety sheet)

Cefradroxil Synthesis Reference

L. B. Crast, Jr., U.S. Pat. 3,489,752 (1969)

Cefradroxil Molecular Weight

363.389 g/mol

Cefradroxil Melting Point


Cefradroxil H2O Solubility

1110 mg/L

Cefradroxil State


Cefradroxil LogP


Cefradroxil Dosage Forms

Capsule; Tablet; Oral liquid

Cefradroxil Indication

For the treatment of the following infections (skin, UTI, ENT) caused by; S. pneumoniae, H. influenzae, staphylococci, S. pyogenes (group A beta-hemolytic streptococci), E. coli, P. mirabilis, Klebsiella sp, coagulase-negative staphylococci and Streptococcus pyogenes

Cefradroxil Pharmacology

Cefadroxil, a first-generation cephalosporin antibiotic, is used to treat urinary tract infections, skin and skin structure infections, pharyngitis, and tonsillitis.

Cefradroxil Absorption

Cefadroxil is well absorbed on oral administration; food does not interfere with its absorption.

Cefradroxil side effects and Toxicity

Nausea, vomiting, diarrhoea, allergic rashes may occur

Cefradroxil Patient Information

Patients should be counseled that intibacterial drugs including DURICEF should only be used to treat bacterial infections. They do not treat viral infections (eg. the common cold). When DURICEF is prescribed to treat a bacterial infection, patients should be told that although it is common to feel better early in the course of therapy, the medication should be taken exactly as directed. Skipping doses or not completing the full course of therapy may (1) decrease the effectiveness of the immediate treatment and (2) increase the likelyhood that bacteria will develop resistance and will not be treatable by DURICEF or other antibacterial drugs in the future.

Cefradroxil Organisms Affected

Enteric bacteria and other eubacteria